日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting pathogenic Th17.1 cells via JAK-STAT3 pathway: A novel approach with tofacitinib for refractory myasthenia gravis

通过JAK-STAT3通路靶向致病性Th17.1细胞：托法替尼治疗难治性重症肌无力的新方法

期刊:Neurotherapeutics
影响因子:6.9
doi:10.1016/j.neurot.2026.e00831
Zhao, Rui; Yan, Chong; Zhong, Huahua; Huan, Xiao; Jin, Lei; He, Dingxian; Xi, Jianying; Li, Yarong; Xiao, Baoguo; Luo, Feifei; Zhao, Chongbo; Song, Jie; Luo, Sushan
重症肌无力
JAK/STAT
信号转导
STAT3
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Predictors of exacerbation in myasthenia gravis after minimal symptom expression: a bicenter cohort study

重症肌无力症状轻微后病情加重的预测因素：一项双中心队列研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1786218
He, Dingxian; Chen, Hongxi; Zhong, Huahua; Zhang, Nana; Yan, Chong; Song, Jie; Xi, Jianying; Luo, Sushan; Zhao, Chongbo; Zhou, Hongyu
重症肌无力
免疫/内分泌
发表日期：2026
文献求助 收藏

Who Can Safely Discontinue Treatment in Myasthenia Gravis? Insights From a Long-Term Real-World Study

哪些重症肌无力患者可以安全停止治疗？一项长期真实世界研究的启示

期刊:European Journal of Neurology
影响因子:3.9
doi:10.1111/ene.70569
He, Dingxian; Yan, Chong; Wang, Baitong; Yang, Yanlei; Gu, Shengying; Xi, Jianying; Luo, Sushan; Zhao, Chongbo
重症肌无力
免疫/内分泌
发表日期：2026
文献求助 收藏

Rituximab for refractory ocular symptoms in myasthenia gravis with thyroid eye disease: a case report with quantitative MRI assessment

利妥昔单抗治疗伴有甲状腺眼病的重症肌无力难治性眼部症状：一例定量MRI评估病例报告

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1717260
He, Dingxian; Li, Xiangwen; Wang, Baitong; Wang, Yaqi; Yan, Chong; Liu, Mengxiao; Hibert, Tom; Luo, Sushan; Zhao, Chongbo; Xi, Jianying
重症肌无力
免疫/内分泌
发表日期：2025
文献求助 收藏

Serum cystatin C as a potential biomarker for generalized acetylcholine receptor antibody-positive myasthenia gravis.

血清胱抑素C作为全身性乙酰胆碱受体抗体阳性重症肌无力的潜在生物标志物

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1578359
He Dingxian, Zhong Huahua, Jin Lei, Chen Ran, Wu Zongtai, Zhao Rui, Huan Xiao, Yan Chong, Song Jie, Xi Jianying, Zhao Chongbo, Zhu Shanfeng, Luo Sushan
其它
发表日期：2025
文献求助 收藏

Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis

艾夫加替莫德用于肌肉特异性激酶型重症肌无力的诱导和维持治疗

期刊:Therapeutic Advances in Neurological Disorders
影响因子:4.1
doi:10.1177/17562864251326778
Zhou, Yufan; Zhou, Qian; Yue, Yaoxian; Luo, Sushan; Song, Jie; Yan, Chong; He, Dingxian; Zhang, Jialong; Zhu, Wenhua; Zhao, Chongbo; Yang, Huan; Wang, Qinzhou; Xi, Jianying
信号转导
重症肌无力
免疫/内分泌
发表日期：2025
文献求助 收藏

Kimura Disease: Retrospective Analysis of 53 Cases and Three Mepolizumab-Responsive Cases

木村病：53例病例回顾性分析及3例美泊利单抗治疗有效病例

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S538560
Zhu, Wenjiao; Zhang, Lei; Zhang, Jing; Wang, Wei; Xiang, Ye; He, Dingxian; Shi, Jing; Liang, Yiran; Shi, Yuanping; Ning, Xianhui; Jin, Meiling; Ye, Ling
发表日期：2025
文献求助 收藏

AB018. Targeted biologics for treating thymoma associated myasthenia gravis: a multicenter retrospective study

AB018. 靶向生物制剂治疗胸腺瘤相关重症肌无力：一项多中心回顾性研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14020553
Schuldesz, Amanda Claudia; Tudor, Raluca; Cornea, Amalia; Geni, Dorina Nicola; Lata, Irina Nicoleta; Simu, Mihaela; Jin, Lei; He, Dingxian; Chen, Hongxi; Zhou, Hongyu; Zeng, Quantao; Tan, Song; Shi, Jianquan; Liu, Ying; Zou, Zhangyu; Song, Jie; Yan, Chong; Huan, Xiao; Wang, Yuan; Yang, Lei; Xi, Jianying; Wu, Zongtai; Zheng, Jianming; Zhao, Chongbo; Chu, Xianglin; Luo, Sushan
免疫/内分泌
胸腺瘤
重症肌无力
发表日期：2025
文献求助 收藏

Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study

依库珠单抗治疗胸腺瘤相关重症肌无力：一项真实世界队列研究

期刊:Therapeutic Advances in Neurological Disorders
影响因子:4.1
doi:10.1177/17562864241309431
Jin, Lei; He, Dingxian; Zeng, Quantao; Tan, Song; Shi, Jianquan; Liu, Ying; Zou, Zhangyu; Song, Jie; Yan, Chong; Huan, Xiao; Wang, Yuan; Yang, Lei; Xi, Jianying; Wu, Zongtai; Liu, Ziqi; Zheng, Jianming; Zhao, Chongbo; Chu, Xianglin; Luo, Sushan
胸腺瘤
重症肌无力
免疫/内分泌
发表日期：2024
文献求助 收藏